Cargando…
Topical Drug Delivery to the Posterior Segment of the Eye: Addressing the Challenge of Preclinical to Clinical Translation
Topical delivery of therapeutics to the posterior segment of the eye remains the “holy grail” of ocular drug delivery. As an example, anti–vascular endothelial growth factor biologics, such as ranibizumab, aflibercept, and bevacizumab, are delivered by intravitreal injection to treat neovascular age...
Autores principales: | Rodrigues, Gerard A., Lutz, David, Shen, Jie, Yuan, Xiaoda, Shen, Hong, Cunningham, James, Rivers, Hongwen M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208585/ https://www.ncbi.nlm.nih.gov/pubmed/30374744 http://dx.doi.org/10.1007/s11095-018-2519-x |
Ejemplares similares
-
Pharmaceutical Development of AAV-Based Gene Therapy Products for the Eye
por: Rodrigues, Gerard A., et al.
Publicado: (2018) -
Topical Drug Delivery to the Posterior Segment of the Eye
por: Löscher, Marina, et al.
Publicado: (2022) -
Translational Preclinical Pharmacologic Disease Models for Ophthalmic Drug Development
por: Shah, Mihir, et al.
Publicado: (2019) -
Delivery of Topically Applied Calpain Inhibitory Peptide to the Posterior Segment of the Rat Eye
por: Ozaki, Taku, et al.
Publicado: (2015) -
Feasibility of drug delivery to the eye's posterior segment by topical instillation of PLGA nanoparticles
por: Tahara, Kohei, et al.
Publicado: (2017)